GI Alliance Southlake

Clinical research site in Southlake, Texas

Part of GI Alliance

As of July 2026, 6 paid clinical trials are recruiting at GI Alliance Southlake in Southlake, Texas. Active studies at this site cover conditions such as Metabolic Dysfunction-Associated Steatotic Liver Disease and Moderately to Severely Active Crohns Disease. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at GI Alliance Southlake (6)

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

for Metabolic Dysfunction-Associated Steatotic Liver Disease

141 locations incl. Tuscaloosa

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07165028·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

for Crohn Disease

55 locations incl. Chandler

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07196722·Phase 2, Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

for Colitis, Ulcerative

51 locations incl. Chandler

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 12+

Code: NCT07196748·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

for Crohn's Disease

71 locations incl. Sun City

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 16 - 80

Code: NCT06430801·Phase 3·Recruiting·Listed May 2024

Apply to this trial

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for Moderately to Severely Active Crohns Disease

92 locations incl. Dothan

Sponsor: Hoffmann-La Roche

Sex: All·Age: 16 - 80

Code: NCT06819878·Phase 3·Recruiting·Listed Feb 2025

Apply to this trial

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

for Crohn Disease

12 locations incl. Bristol

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: All ages

Code: NCT06651281·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

More research sites in Southlake

Retina Center of Texas (6 trials)
Texas Digestive Disease Consultants - Southlake (3 trials)
89bio Clinical Study Site (2 trials)
Epiphany Dermatology (2 trials)
GI Alliance - Southlake (2 trials)
Stryde Research-Epiphany Dermatology (2 trials)
Texas Digestive Disease Consultants (TDDC), Southlake (2 trials)
Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake (2 trials)
Stryde Research - Epiphany Dermatology (2 trials)
Castle Surg Ctr (1 trial)

Explore more

Paid clinical trials in Southlake, TX · Texas clinical trials